[Classification, pathogenesis and drug therapy of migraine and related forms of headache].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D003000:Clonidine / Q000494:pharmacology; D004087:Dihydroergotamine / Q000494:pharmacology; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D004878:Ergotamine / Q000097:blood / Q000494:pharmacology; D006261:Headache / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D006632:Histamine; D006801:Humans; D008784:Methysergide / Q000494:pharmacology; D051379:Mice; D008881:Migraine Disorders / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D009638:Norepinephrine / Q000494:pharmacology; D010918:Pizotyline / Q000494:pharmacology; D012701:Serotonin
D000319:Adrenergic beta-Antagonists; D010918:Pizotyline; D012701:Serotonin; D002110:Caffeine; D004087:Dihydroergotamine; D006632:Histamine; D003000:Clonidine; D004878:Ergotamine; D009638:Norepinephrine; D008784:Methysergide; D004837:Epinephrine
Einteilung, Pathogenese und medikamentöse Behandlung der Migräne und verwandter Kopfschmerzen